Results 321 to 330 of about 623,894 (355)
Some of the next articles are maybe not open access.

Paraneoplastic mononeuritis multiplex in non-small-cell lung carcinoma

Journal of Clinical Neuroscience, 2006
A 60-year-old man developed two selective peripheral mononeuropathies of the peroneal and later the radial nerve, shortly after a diagnosis of large-cell lung carcinoma. Nerve conduction studies and electromyography confirmed isolated lesions in both nerves, and in the case of the peroneal nerve lesion, focal conduction block was localised to the level
Annabel C, Martin   +2 more
openaire   +2 more sources

Non-Small-Cell Carcinoma of the Lung

1991
It is estimated that in the United States during 1989, 155000 cases of carcinoma of the lung will occur and that close to 142000 of these patients will die within 1 year from their disease (Silver-Berg and Lubera 1989). At present in the United States, the incidence and death rate from this disease for females has surpassed that for breast cancer in ...
Hassan Aziz   +4 more
openaire   +1 more source

Chronic oral etoposide in non-small cell lung carcinoma

European Journal of Cancer, 1992
25 consecutive inoperable or extended non-small cell lung cancer (NSCLC) patients (19 non-chemotherapy pretreated, 6 non-heavily pretreated) were given oral etoposide, 50 mg/m2/day for 21 successive days, every 4 weeks. 5 partial responses (PR), 9 disease stabilizations were achieved; the overall response rate of 20% (95% confidence interval, 4% to 36%)
J, Estapé   +9 more
openaire   +2 more sources

Unresectable non-small cell lung carcinoma

Revisiones en Cáncer, 2023
Ivana Sullivan   +2 more
openaire   +1 more source

[Diagnostics of non-small cell lung carcinoma].

Duodecim; laaketieteellinen aikakauskirja, 2014
ALK inhibitor therapy is individual cancer treatment, in which the targeted drug therapy is directed to a patient group that is likely to benefit from the therapy. The detection in the tumor of ALK gene (anaplastic lymphoma kinase) rearrangement is a prerequisite for the ALK inhibitor therapy for non-small cell lung carcinoma.
Kaisa, Salmenkivi, Aija, Knuuttila
openaire   +1 more source

Non–Small Cell Lung Carcinoma

Pathology Case Reviews, 2009
Michael O. Idowu   +2 more
openaire   +1 more source

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

Ca-A Cancer Journal for Clinicians, 2021
Hyuna Sung   +2 more
exaly  

Non-small cell lung carcinoma. Clinical case

Filin’s Clinical endoscopy
In 2020, 2.2 million new cases of lung cancer were reported. The main form of lung cancer is non-small cell carcinoma (85%). Non-small cell lung cancer has 3 subtypes: adenocarcinoma, large cell and squamous cell carcinoma. Squamous cell lung cancer occurs in 20-40% of all lung cancers.
openaire   +1 more source

Cancer statistics, 2022

Ca-A Cancer Journal for Clinicians, 2022
Rebecca L Siegel   +2 more
exaly  

Cancer statistics, 2023

Ca-A Cancer Journal for Clinicians, 2023
Rebecca L Siegel   +2 more
exaly  

Home - About - Disclaimer - Privacy